0001474720-25-000003.txt : 20250806 0001474720-25-000003.hdr.sgml : 20250806 20250806171713 ACCESSION NUMBER: 0001474720-25-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20250806 DATE AS OF CHANGE: 20250806 EFFECTIVENESS DATE: 20250806 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Neuros Medical, Inc. CENTRAL INDEX KEY: 0001474720 ORGANIZATION NAME: EIN: 263646315 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-553915 FILM NUMBER: 251190684 BUSINESS ADDRESS: STREET 1: 26800 ALISO VIEJO PARKWAY STREET 2: SUITE 250 CITY: ALISO VIEJO STATE: CA ZIP: 92656 BUSINESS PHONE: 440-951-2565 MAIL ADDRESS: STREET 1: 26800 ALISO VIEJO PARKWAY STREET 2: SUITE 250 CITY: ALISO VIEJO STATE: CA ZIP: 92656 D 1 primary_doc.xml X0708 D LIVE 0001474720 Neuros Medical, Inc. 26800 Aliso Viejo Pkwy, Suite 250 Aliso Viejo CA CALIFORNIA 92656 440-951-2565 DELAWARE None None Corporation true David Veino 26800 Aliso Viejo Pkwy, Suite 250 Aliso Viejo CA CALIFORNIA 92656 Executive Officer Director President, Chief Executive Officer, and Secretary Zach Stassen 26800 Aliso Viejo Pkwy, Suite 250 Aliso Viejo CA CALIFORNIA 92656 Executive Officer Chief Financial Officer William Harrington 26800 Aliso Viejo Pkwy, Suite 250 Aliso Viejo CA CALIFORNIA 92656 Director Marc-Andre Marcotte 26800 Aliso Viejo Pkwy, Suite 250 Aliso Viejo CA CALIFORNIA 92656 Director Casey Tansey 26800 Aliso Viejo Pkwy, Suite 250 Aliso Viejo CA CALIFORNIA 92656 Director Joyce Erony 26800 Aliso Viejo Pkwy, Suite 250 Aliso Viejo CA CALIFORNIA 92656 Director Fouad Azzam 26800 Aliso Viejo Pkwy, Suite 250 Aliso Viejo CA CALIFORNIA 92656 Director Randy Ban 26800 Aliso Viejo Pkwy, Suite 250 Aliso Viejo CA CALIFORNIA 92656 Director Biotechnology Decline to Disclose 06b false 2025-07-09 false true false 0 64999994 55999997 8999997 false 28 0 0 0 false Neuros Medical, Inc. /s/ David Veino David Veino President & CEO 2025-08-06